On Monday, 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) opened lower -14.65% from the last session, before settling in for the closing price of $0.73. Price fluctuations for SXTP have ranged from $0.70 to $7.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 2.28%. Company’s average yearly earnings per share was noted 69.05% at the time writing. With a float of $1.84 million, this company’s outstanding shares have now reached $1.86 million.
Let’s determine the extent of company efficiency that accounts for 3 employees. In terms of profitability, gross margin is 8.19%, operating margin of -2119.47%, and the pretax margin is -1767.95%.
60 Degrees Pharmaceuticals Inc (SXTP) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 60 Degrees Pharmaceuticals Inc is 20.10%, while institutional ownership is 10.01%. The most recent insider transaction that took place on Dec 13 ’24, was worth 9,375. In this transaction Director of this company bought 6,000 shares at a rate of $1.56, taking the stock ownership to the 52,078 shares. Before that another transaction happened on Dec 12 ’24, when Company’s Director bought 5,000 for $1.82, making the entire transaction worth $9,125. This insider now owns 46,078 shares in total.
60 Degrees Pharmaceuticals Inc (SXTP) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 69.05% per share during the next fiscal year.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
Check out the current performance indicators for 60 Degrees Pharmaceuticals Inc (SXTP). In the past quarter, the stock posted a quick ratio of 4.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.94, a number that is poised to hit -0.80 in the next quarter and is forecasted to reach -1.66 in one year’s time.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
Looking closely at 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP), its last 5-days average volume was 13.61 million, which is a jump from its year-to-date volume of 4.1 million. As of the previous 9 days, the stock’s Stochastic %D was 10.13%. Additionally, its Average True Range was 0.17.
During the past 100 days, 60 Degrees Pharmaceuticals Inc’s (SXTP) raw stochastic average was set at 4.81%, which indicates a significant decrease from 14.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 204.80% in the past 14 days, which was higher than the 155.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1400, while its 200-day Moving Average is $1.8503. However, in the short run, 60 Degrees Pharmaceuticals Inc’s stock first resistance to watch stands at $0.7116. Second resistance stands at $0.8033. The third major resistance level sits at $0.8964. If the price goes on to break the first support level at $0.5268, it is likely to go to the next support level at $0.4337. Should the price break the second support level, the third support level stands at $0.3420.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Key Stats
There are currently 2,297K shares outstanding in the company with a market cap of 2.72 million. Presently, the company’s annual sales total 250 K according to its annual income of -3,770 K. Last quarter, the company’s sales amounted to 150 K and its income totaled -2,160 K.
